Mapping genetic factors of cardiovascular disease in Hispanic and Latino populations
Official title: Leveraging Hispanic/Latino diversity to map and characterize cardiovascular disease loci
Funded at Univ of North Carolina Chapel Hill · NIH-11021070 · Data updated 2026-11-12
This study is looking at how genes might affect heart disease in Hispanic and Latino communities, with the goal of finding ways to better prevent and treat heart-related health issues like obesity, diabetes, and high blood pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | January 16, 2023 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $646,864 |
| NIH project number | 5R01HL163262-03 |
| Project ID | NIH-11021070 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Hispanic and Latino individuals who are at risk for cardiovascular disease or related conditions.
✕Less likely to help
Patients who do not identify as Hispanic or Latino or those without risk factors for cardiovascular disease may not benefit from this research.
What this research studies
This research investigates the genetic factors contributing to cardiovascular disease (CVD) specifically in Hispanic and Latino populations, who face unique health disparities. By conducting genome-wide association studies (GWAS), the research aims to identify genetic loci associated with CVD risk factors such as obesity, type 2 diabetes, and hypertension. The study will enrich the understanding of how these genetic factors influence health outcomes, ultimately aiming to improve prevention and treatment strategies for CVD in these communities.
Why it matters
Potential benefit: If successful, this research could lead to better-targeted prevention and treatment strategies for cardiovascular disease in Hispanic and Latino populations.
How similar studies have gone: Previous research has shown success in identifying genetic factors for cardiovascular disease in other populations, but this specific focus on Hispanic and Latino groups is relatively novel.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Graff, Mariaelisa — Univ of North Carolina Chapel Hill
- Study coordinator: Graff, Mariaelisa
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Food allergy antibodies linked to heart disease risk in adults
Many adults have antibodies to foods without symptoms, and this study asks whether those antibodies are linked to higher risk of heart disease and related conditions.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
Integrating heart care into HIV services in Botswana using statins
This project tests a simple, scalable approach to help people with HIV in Botswana start and stay on statin therapy to prevent heart attacks and strokes.
-
A heart-healthy program for aging HIV patients using therapy pets to help blood pressure
A study tests whether using the human-animal bond from dog ownership can help older adults living with HIV control their blood pressure and improve heart health.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.